Assenagon Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3M Buy
218,270
+155,011
+245% +$18.8M 0.03% 377
2026
Q1
$10.3M Sell
63,259
-43,567
-41% -$6.7M 0.02% 452
2025
Q4
$18.6M Sell
106,826
-22,419
-17% -$4.09M 0.03% 374
2025
Q3
$18.6M Buy
129,245
+55,841
+76% +$6.84M 0.03% 382
2025
Q2
$7.39M Buy
73,404
+33,626
+85% +$2.57M 0.01% 509
2025
Q1
$3.03M Sell
39,778
-485,415
-92% -$37.1M 0.01% 656
2024
Q4
$36.3M Sell
525,193
-332,167
-39% -$23.9M 0.06% 262
2024
Q3
$62.6M Buy
857,360
+466,306
+119% +$34.4M 0.12% 154
2024
Q2
$26.2M Sell
391,054
-820,506
-68% -$31.8M 0.06% 245
2024
Q1
$32.9M Buy
1,211,560
+927,040
+326% +$25.9M 0.08% 201
2023
Q4
$8.82M Buy
284,520
+22,384
+9% +$580K 0.02% 485
2023
Q3
$6.62M Sell
262,136
-1,519,918
-85% -$34.8M 0.02% 503
2023
Q2
$37.6M Buy
1,782,054
+374,715
+27% +$7.11M 0.13% 133
2023
Q1
$24M Buy
1,407,339
+359,175
+34% +$6.98M 0.09% 202
2022
Q4
$20.9M Sell
1,048,164
-595,708
-36% -$11.5M 0.08% 237
2022
Q3
$35.4M Buy
1,643,872
+384,952
+31% +$9.23M 0.14% 147
2022
Q2
$24.8M Buy
1,258,920
+455,186
+57% +$9.54M 0.09% 197
2022
Q1
$18.9M Buy
803,734
+794,864
+8,961% +$18.5M 0.05% 250
2021
Q4
$242K Buy
+8,870
New +$254K ﹤0.01% 1334
2021
Q1
Sell
-44,014
Closed -$1.47M 1247
2020
Q4
$1.47M Buy
+44,014
New +$1.61M 0.01% 608

Other funds holding INSM

Assenagon Asset Management's INSM Position: Q2 2026 in Review

Assenagon Asset Management increased its Insmed (INSM) stake by 245% in Q2 2026, buying an estimated $18.8M and bringing the position to 218,270 shares worth $23.3M. The position accounts for 0.03% of the portfolio, ranked #377.

Assenagon Asset Management first reported a position in INSM in Q4 2020 and has held it in 20 quarters since. The position peaked at $62.6M in Q3 2024. 63 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Assenagon Asset Management held 218,270 shares of Insmed worth $23.3M as of Q2 2026.
  • Assenagon Asset Management bought 155,011 Insmed shares in Q2 2026, an estimated $18.8M.
  • Insmed made up 0.03% of Assenagon Asset Management's portfolio in Q2 2026, its #377 holding.
  • Assenagon Asset Management first reported a position in Insmed in Q4 2020 and has held it in 20 quarters since.
  • Assenagon Asset Management's Insmed position peaked at $62.6M in Q3 2024.
  • 63 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.